Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2011

01.04.2011 | Research Article

How do pharmacists respond to complaints of acute insomnia? A simulated patient study

verfasst von: Carly Kippist, Keith Wong, Delwyn Bartlett, Bandana Saini

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective It is known that many people with insomnia choose to self medicate and present at community pharmacies, particularly in cases of acute insomnia. The objective of this study is to investigate how community pharmacists respond to complaints of acute insomnia from people who seek self treatment and determine the factors affecting this response. Setting Community pharmacies in New South Wales, Australia. Method A simulated patient study was conducted in 100 randomly selected pharmacies located in Newcastle and Sydney, Australia. A standardized scenario of acute sleep onset insomnia and a scoring system was used in each pharmacy. Main outcome measures Main outcome measures included supply/non supply of an over the counter sleep aid to the simulated patient, and scores for pharmacists for skills in eliciting information prior to supply of medication (Pre Supply Score), counseling about medication (Supply Score), or about sleep (Sleep Score). Results Of the 100 pharmacies, upon simulated patient presentation, 96% supplied a product, the remaining 4% referred to a physician. Non-pharmacological advice was provided in 42%. Pharmacists scored highly on advice provided with supply of a medication (Supply scores/4, 3.1 ± 0.9), but lower on skills in eliciting information prior to supply (Pre-supply score/8, 3.6 ± 1.9) and sleep related counselling (Sleep Score/9, 2.1 ± 1.7). Lower estimated pharmacist age, being in a chain type pharmacy, and having a visible symbol of quality accreditation were found to significantly improve (P < 0.05 the Sleep Score outcome. Lower estimated pharmacist age as also significantly associated with higher Supply Score (P < 0.05); whilst both lower estimated age an visible quality assurance signage were associated with higher Pre-Supply scores (P < 0.05). Conclusion The results of this study suggest that many pharmacists are responding appropriately to complaints of sleeplessness in terms of eliciting insomnia type and counseling about medicines use. However more education for pharmacists would help to further promote good sleep health, and address behaviors including reliance on medicines taking that can progressively worsen insomnia.
Literatur
1.
Zurück zum Zitat Bhat A, Shafi F, Solh A. Pharmacotherapy of insomnia. Expert Opin Pharmacother. 2008;9(3):351–62.PubMedCrossRef Bhat A, Shafi F, Solh A. Pharmacotherapy of insomnia. Expert Opin Pharmacother. 2008;9(3):351–62.PubMedCrossRef
2.
Zurück zum Zitat Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.PubMed Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.PubMed
3.
Zurück zum Zitat Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm. 2008;65(10):927–34.PubMedCrossRef Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm. 2008;65(10):927–34.PubMedCrossRef
4.
Zurück zum Zitat Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11(1):71–9.PubMedCrossRef Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11(1):71–9.PubMedCrossRef
5.
Zurück zum Zitat Sivertsen B, Krokstad S, Mykletun A, Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med. 2009;7(4):210–22.PubMedCrossRef Sivertsen B, Krokstad S, Mykletun A, Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med. 2009;7(4):210–22.PubMedCrossRef
6.
Zurück zum Zitat Morin CM, LeBlanc M, Daley M, Grégoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–30.PubMedCrossRef Morin CM, LeBlanc M, Daley M, Grégoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–30.PubMedCrossRef
7.
Zurück zum Zitat Taylor DJ, Lichstein KL, Durrence H, Riedel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–64.PubMed Taylor DJ, Lichstein KL, Durrence H, Riedel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–64.PubMed
8.
Zurück zum Zitat Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411–8.PubMedCrossRef Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411–8.PubMedCrossRef
9.
Zurück zum Zitat Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163(11):1018–24.PubMedCrossRef Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163(11):1018–24.PubMedCrossRef
10.
Zurück zum Zitat Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents Sleep Med. doi:10.1016/j.sleep.2008.04.005. Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents Sleep Med. doi:10.​1016/​j.​sleep.​2008.​04.​005.
11.
Zurück zum Zitat Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med. 2008;9(8):857–64.PubMedCrossRef Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med. 2008;9(8):857–64.PubMedCrossRef
12.
Zurück zum Zitat Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J. 2008;38(1):24–31.PubMed Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J. 2008;38(1):24–31.PubMed
13.
Zurück zum Zitat Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18(4):163–76.PubMedCrossRef Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18(4):163–76.PubMedCrossRef
15.
Zurück zum Zitat Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511–5.PubMedCrossRef Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511–5.PubMedCrossRef
16.
Zurück zum Zitat Leybishkis B, Fasseas P, Ryan K. Doxylamine overdose as a potential cause of rhabdomyolysis. Am J Med Science. 2001;322(1):48–9.CrossRef Leybishkis B, Fasseas P, Ryan K. Doxylamine overdose as a potential cause of rhabdomyolysis. Am J Med Science. 2001;322(1):48–9.CrossRef
17.
Zurück zum Zitat Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2009;23(1):101–5.PubMedCrossRef Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2009;23(1):101–5.PubMedCrossRef
18.
Zurück zum Zitat Benrimoj SI, Werner JB, Raffaele C, et al. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci. 2008;30(2):147–53.PubMedCrossRef Benrimoj SI, Werner JB, Raffaele C, et al. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci. 2008;30(2):147–53.PubMedCrossRef
19.
Zurück zum Zitat Black J, Saini B, Wong K. The role of pharmacists in improving the management of sleep disorders in the community. Respirology. 2007;12(1):A24. Black J, Saini B, Wong K. The role of pharmacists in improving the management of sleep disorders in the community. Respirology. 2007;12(1):A24.
20.
Zurück zum Zitat Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practicing community pharmacists. J Clin Pharm Ther. 2008;33:641–52.PubMedCrossRef Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practicing community pharmacists. J Clin Pharm Ther. 2008;33:641–52.PubMedCrossRef
21.
Zurück zum Zitat Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto A. Non-prescription medicines: a process for standards development and testing in community pharmacies. Pharm World Sci. 2007;29:386–94.PubMedCrossRef Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto A. Non-prescription medicines: a process for standards development and testing in community pharmacies. Pharm World Sci. 2007;29:386–94.PubMedCrossRef
22.
Zurück zum Zitat Schneider C, Everett W, Geelhoed E, Kendall P, Clifford R. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512–8.PubMedCrossRef Schneider C, Everett W, Geelhoed E, Kendall P, Clifford R. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512–8.PubMedCrossRef
23.
Zurück zum Zitat Puumalainen II, Peura SH, Kansanaho HM, Benrimoj SI, Airaksinen M. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Prac. 2005;13:149–56.CrossRef Puumalainen II, Peura SH, Kansanaho HM, Benrimoj SI, Airaksinen M. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Prac. 2005;13:149–56.CrossRef
24.
Zurück zum Zitat Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.PubMedCrossRef Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.PubMedCrossRef
25.
Zurück zum Zitat Granas AG, Haugli A, Horn AM. Smoking cessation advice provided in 53 Norwegian pharmacies. Int J Pharm Pract. 2004;12(4):179–84.CrossRef Granas AG, Haugli A, Horn AM. Smoking cessation advice provided in 53 Norwegian pharmacies. Int J Pharm Pract. 2004;12(4):179–84.CrossRef
26.
Zurück zum Zitat Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants’ practice in dealing with direct requests for analgesics. Int J Pharm Pract. 2002;10:23–9.CrossRef Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants’ practice in dealing with direct requests for analgesics. Int J Pharm Pract. 2002;10:23–9.CrossRef
27.
Zurück zum Zitat Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171–8.CrossRef Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171–8.CrossRef
28.
Zurück zum Zitat Watson MC, Hart J, Johnston M, et al. Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci. 2008;30(5):526–35.PubMedCrossRef Watson MC, Hart J, Johnston M, et al. Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci. 2008;30(5):526–35.PubMedCrossRef
29.
Zurück zum Zitat Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a “mystery shopper” study. Pharm World Sci. 2002;24(4):149–53.CrossRef Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a “mystery shopper” study. Pharm World Sci. 2002;24(4):149–53.CrossRef
30.
Zurück zum Zitat Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. Canberra: The Society, 2010. Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. Canberra: The Society, 2010.
31.
Zurück zum Zitat Morgan M, Jenkins L, Risdale L. Patient pressure for referral for headache: a qualitative study of GPs referral behavior. Br J Gen Prac. 2007;57:29–35. Morgan M, Jenkins L, Risdale L. Patient pressure for referral for headache: a qualitative study of GPs referral behavior. Br J Gen Prac. 2007;57:29–35.
32.
Zurück zum Zitat Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician. 2009;38(5):283.PubMed Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician. 2009;38(5):283.PubMed
33.
Zurück zum Zitat Smith L, Bosnic-Anticevich S, Mitchell B, Krass I, Saini B, Armour C. Treating asthma with a self-management model of illness behavior in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501–11.PubMedCrossRef Smith L, Bosnic-Anticevich S, Mitchell B, Krass I, Saini B, Armour C. Treating asthma with a self-management model of illness behavior in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501–11.PubMedCrossRef
34.
Zurück zum Zitat O’Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Pat Educ Couns. 2008;70:111–7.CrossRef O’Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Pat Educ Couns. 2008;70:111–7.CrossRef
35.
Zurück zum Zitat Espie C, MacMahon K, Kelly H. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavioral therapy for persistent insomnia in general practice. Sleep. 2007;30:574–84.PubMed Espie C, MacMahon K, Kelly H. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavioral therapy for persistent insomnia in general practice. Sleep. 2007;30:574–84.PubMed
36.
Zurück zum Zitat Alte D, Weitschies W, Ritter C. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007;41:1023–30.PubMedCrossRef Alte D, Weitschies W, Ritter C. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007;41:1023–30.PubMedCrossRef
37.
Zurück zum Zitat Svarstad B, Bultman D, Mount J. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age and busyness. J Am Pharm Assoc. 2004;44(1):22–5.CrossRef Svarstad B, Bultman D, Mount J. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age and busyness. J Am Pharm Assoc. 2004;44(1):22–5.CrossRef
Metadaten
Titel
How do pharmacists respond to complaints of acute insomnia? A simulated patient study
verfasst von
Carly Kippist
Keith Wong
Delwyn Bartlett
Bandana Saini
Publikationsdatum
01.04.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9482-5

Weitere Artikel der Ausgabe 2/2011

International Journal of Clinical Pharmacy 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.